12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers NanoString Technologies (NASDAQ:NSTG) shares moved upwards by 16.5% to $0.06 during Wednesday’s after-market session. The market value…
Earnings Preview For Sensus Healthcare
Sensus Healthcare (NASDAQ:SRTS) is set to give its latest quarterly earnings report on Thursday, 2024-02-08. Here’s what investors…
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares moved upwards by 46.5% to $1.67 during Tuesday’s regular session. The market value…
Sensus Healthcare Announces Preliminary Q4 Revenue Of $12M And 2023 Revenue Exceeding $23M
Ships more than 60 SRT units in 2023To report full financial results and hold conference call on February 8thBOCA RATON, Fla. , Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers TRACON Pharma (NASDAQ:TCON) stock increased by 71.3% to $0.27 during Thursday’s after-market session. This security traded at…
Sensus Healthcare: Q3 Earnings Insights
Sensus Healthcare (NASDAQ:SRTS) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:05 PM. Here’s what…
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell
• Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Preview: Sensus Healthcare’s Earnings
Sensus Healthcare (NASDAQ:SRTS) is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here’s what investors…
Sensus Healthcare To Showcase Its Full Line Of Cutting-Edge Superficial Radiotherapy Devices For The Treatment Of Non-Melanoma Skin Cancer At ASTRO 2023 In San Diego
Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces